Chemeq says it will meet production requirements

By Melissa Trudinger
Tuesday, 08 March, 2005

Chemeq (ASX:CMQ) has clarified its current and future production capabilities after questions were raised in a research report about the ability of the company to produce the levels of product required by new investment partner Mizuho.

As one of the conditions of the company's AUD$60 million rescue by Mizuho, Chemeq is required to obtain confirmed sales orders for a minimum of 40,000 litres of its polymeric antimicrobial in the 2005-2006 financial year by the end of September this year.

But a recent issue of biotech investor newsletter Bioshares questioned whether the company's production levels were adequate to meet this.

Now the company has confirmed that its current production levels are 60,000-100,000 litres of product, which equates to approximately 15-25 per cent of plant capacity. Ultimately, the plant is expected to reach a production output of 400,000 litres of finished product.

Related News

Immune cell boost could enable lasting vaccine protection

A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...

Genes influence when babies start walking

Genetics accounts for about a quarter of the differences in when children take their first steps,...

Novel glycopeptide antibiotic candidate shows promise

Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd